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The periodic-fever syndromes are a genetically hetero-
geneous group of inflammatory disorders characterized
by recurrent fever, abdominal pain, and polyserositis.
The clinically distinct entities of familial Mediterranean
fever (FMF; MIM 249100) and hyperimmunoglobuli-
nemia D with periodic fever (MIM 260920) are auto-
somal recessive and genetically distinct. Two Turkish
families with clinical features of FMF do not link to the
FMF region on chromosome 16p13.3, suggesting genetic
heterogeneity for FMF (Akarsu et al. 1997). Vertically
transmitted periodic fevers with autosomal dominant in-
heritance are rarer than FMF; these include Hibernian
fever (MIM 142680) and other families in which allelism
to Hibernian fever remains to be tested. Vertical trans-
mission in families of Mediterranean origin does not rule
out autosomal recessive FMF exhibiting pseudodomi-
nance, given the relatively high carrier frequencies in
certain ethnic groups and the consanguinity practiced in
some of these. The molecular defects underlying FMF
can now be detected after identification of the MEFV
gene (French FMF Consortium 1997; International FMF
Consortium 1997). Among the autosomal dominant pe-
riodic-fever families, the allelic relationships can now be
inferred by linkage, given the recent localization of Hi-
bernian fever to 12p13 (McDermott et al. 1998; Mulley
et al. 1998). The era of laboratory-based diagnosis for
the periodic fevers has begun.
Aksentijevich et al. (1999 [in this issue]) describe and
expand the spectrum of mutations within MEFV from
an ethnically diverse group. The initial reports based on
non-Ashkenazi Jews, Armenians, Turks, and Arabs pre-
sented just four conservative missense mutations from
MEFV exon 10 (M680I, M694V, M694I, and V726A),
accounting for ∼85% of FMF chromosomes from these
populations (French FMF Consortium 1997; Interna-
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tional FMF Consortium 1997). Bernot et al. (1998) de-
scribed eight additional mutations in patients whose or-
igin was expanded to Afghans, Druze, and French.
Aksentijevich et al. reexamined earlier cases in which
mutations were not detected and expanded their analysis
to include Ashkenazi Jews and Italians. Five of the 16
mutations now known from all studies are found in ex-
ons other than exon 10. Eleven of the mutations found
by Aksentijevich et al. accounted for 79% of the carrier
chromosomes that they detected in 90 ethnically diverse
(i.e., from the United States, Europe, and Israel), mu-
tation-positive individuals. Carrier frequency is esti-
mated to be as high as one in five in northern African
non-Ashkenazi Jews and one in seven in Armenians from
Los Angeles. The frequent occurrence of several MEFV
alleles that are deleterious when homozygous (M694V,
V726A, and E148Q), in different populations all of
Mediterranean origin strongly suggests their mainte-
nance in these populations by pressure from some form
of balancing natural selection. This is most probably
heterozygote advantage in response to an as yet unde-
fined past or present environmental agent localized to
that geographic region. None of the 16 mutations so far
characterized will truncate the protein, so effects of trun-
cation mutations can only be speculated.
An important new finding has been the MEFV mu-
tation E148Q found in exon 2 (Bernot et al. 1998). It
is embedded in multiple microsatellite marker haplo-
types across ethnic groups, but these extragenic micro-
satellite haplotypes have now been shown by means of
MEFV single-nucleotide polymorphisms (SNPs) to con-
verge to a single ancestral haplotype (Aksentijevich et
al. 1999). Similarly, multiple microsatellite haplotypes
containing M694V or M680I mutations from different
ethnic groups had been shown to converge to a single
ancestral intragenic SNP haplotype between exons 3 and
10 (International FMF Consortium 1997). This conver-
gence to ancestral haplotypes argues against recurrent
mutation to the same FMF allele as the source of mu-
tation present in the different ethnic groups, suggesting
instead that each FMF allele originated from a single
founder mutation. Gene migration represents an alter-
native to mutation as a source of genetic variation for
a population, and genetic exchange has almost certainly
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accompanied Mediterranean commerce even prior to
biblical times. Once introduced into adjacent popula-
tions living in similar environmental conditions, natural
selection would promote further dispersal of the original
founder mutation. Thus, the different ethnic groups
eventually share that minute genome segment containing
the MEFV mutation with its surrounding ancestral
haplotype.
The power of intragenic SNPs for establishment of
ancestral relationships of MEFV mutations has been
clearly demonstrated. Their greater stability compared
with microsatellite markers ensures their value for es-
tablishment of ancestral relationships between chro-
mosomal segments. However, in the case ofMEFV, their
intragenic abundance compared with microsatellites is
the crucial factor in their utility. Because the common
MEFV mutations are themselves conservative missense
substitutions, any exonic SNPs represent potential phe-
notypic modifiers for the 16 primary mutations so far
identified.
Reduced penetrance of FMF in females has long been
known; however, reduced penetrance of the E148Q,
P369S, and K695R mutations in the Ashkenazim was
a surprise finding. Therefore, the FMF carrier frequen-
cy within this group has been reassessed and adjusted
upward to 21%, considerably higher than previously
thought. E148Q was the most common mutation. The
explanation for this newfound complexity will likely in-
volve untangling of the interactions between elements of
the genetic background (perhaps even intragenic SNPs)
and/or environmental factors, and comparisons between
affected and unaffected individuals homozygous for the
same mutant alleles are likely to be instructive. Inter-
actions could conceivably exist between pairs of mutant
FMF alleles, between mutant FMF alleles and SNP var-
iation atMEFV, or between mutant FMF alleles and SNP
variation at other loci affecting inflammatory pathways.
Asymptomatic homozygotes for the E148Q, P369S, and
K695R mutations were observed within the Ashke-
nazim, prompting Aksentijevich et al. (1999) to recog-
nize the difficulties in separating harmless exonic SNPs
from pathological variants. Prognosis for these variants
has now been thrown into confusion, except for the fact
that the FMF phenotype within the Ashkenazi Jewish
population is milder than that within the Sephardic Jew-
ish population. There are precedents (e.g., from cystic
fibrosis) suggesting that the phenotype associated with
a primary mutation depends on variation found else-
where in a gene (Kiesewetter et al. 1993).
Another unusual result presented by Aksentijevich et
al. (1999) is detection of a complex allele with a double
mutation in cis configuration in the Ashkenazim. Thus,
some affected FMF family members unexpectedly carry
not two, but threeMEFV mutations. The complex allele
contains E148Q and one of the next-most-frequent mu-
tations in that ethnic group, either P369S or V726A. In
the case of the complex allele E148Q-V726A, family
study of ancestral SNP haplotypes demonstrated likely
formation by a historic intragenic recombination event,
rather than a double mutational hit. The same complex
allele was also seen by Aksentijevich et al. (1999) in
an Italian patient and by Bernot et al. (1998), who
also observed the complex alleles E148Q-I692del and
E167D-F479L. These observations suggest potential
problems with the general utility of SNPs for detection
of associations at the population level, for the purpose
of mapping and identifying genes for polygenic disor-
ders, even by means of dense SNP maps. The simpler,
monogenic MEFV situation demonstrates different an-
cestral SNP haplotypes associated with different FMF
mutations and intragenic scrambling of FMF alleles by
recombination, problems that will be multiplied when
extended to several loci affecting the same phenotype.
Finding double mutations is not new, so how frequent
are these complex alleles? Complex alleles, the segre-
gation of more than one mutation for the same gene
within the same family for X-linked or autosomal dom-
inant disorders, or segregation of mutations with similar
phenotypic consequences at two loci within the one fam-
ily (e.g., breast cancer genes BRCA1 and BRCA2; Fried-
man et al. 1998) fortunately represent rarely encoun-
tered complications for diagnostic laboratories. Double
mutations in cis configuration could arise simultaneously
in the same individual, sequentially on the same chro-
mosome in different generations, or by intragenic re-
combination, as now suggested for FMF. Mutation
screens frequently terminate when “the” mutation (or
two mutations for a patient with an autosomal recessive
disorder) is detected. Perhaps the first example of such
a complex allele was documented for X-linked Du-
chenne/Becker muscular dystrophy (Wilton et al. 1993),
but examples are now also known for cystic fibrosis
(Savov et al. 1995) and autosomal dominant angio-
edema (Verpy et al. 1996). Should the diagnostic labo-
ratory be expected to detect novel double-mutant alleles
or only those double-mutant alleles already character-
ized and known to be present in the ethnic group to
which the patient belongs, as now described forMEFV?
Another feature of the work by Aksentijevich et al.
(1999) is a neat demonstration of pseudodominance in
an Israeli family of Ashkenazi ancestry in whom the
mode of inheritance is not as it initially appeared. Pseu-
dodominance is known for FMF, but in the case of the
Ashkenazim it was considered unlikely because of low
FMF gene frequency. The molecular tools now available
led to detection of MEFV mutations in this family and
to diagnosis of FMF. Vertical transmissionwas explained
by carriers of MEFV mutations who married into the
pedigree in successive generations. Reintroduction of the
same mutant allele identical by descent could easily be
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envisaged through an inbreeding loop; however, for FMF
the same apparent vertical transmission is feasible by the
introduction, into the pedigree, of any of the other com-
mon MEFV mutations known from that ethnic group.
This was found to be the Ashkenazi family, which is far
more plausible now that the FMF carrier frequency in
the Ashkenazim has been revised upward to one in five.
Rapid screening methods are evolving for known
MEFV mutations to facilitate transportability of testing
from research laboratories to diagnostic laboratories
(Bernot et al. 1998; Aksentijevich et al. 1999). Themeth-
odology involves digestion of PCR products in which
mutations have created or destroyed restriction-endonu-
clease sites or amplification-refractory mutation screen-
ing (ARMS), which will significantly affect testing strat-
egy when coupled with knowledge of the ethnic origin
of each patient. The frequency of SNPs complicates sin-
gle-strand conformation analysis to the extent that the
MEFV mutations have been initially detected by direct
sequencing. As other periodic fever genes are identified,
mode of inheritance, as well as clinical evaluations, will
further influence the mutation-testing strategy. The ap-
plication of this technology (or perhaps DNA array tech-
nology in the future) will enable early confirmation
or even presymptomatic diagnosis of periodic fevers,
especially in populations in which the disorder is un-
common and in which it might otherwise remain undi-
agnosed and lead to unnecessary surgery or renal com-
plications. Prognosis may be complicated by incomplete
penetrance and variable expressivity of MEFV muta-
tions; however, early treatment of FMF with colchicine
is known to effectively reduce the chance of renal failure.
The task of identification of the MEFV gene was for-
midable, for what transpired to be a novel gene not
represented in the expressed-sequence-tag databases.
Aksentijevich et al. (1999) have shown that, far from
representing the endpoint, gene identificationwasmerely
the milestone that signaled the beginning of an under-
standing of the molecular basis for periodic fevers. The
current physical and genetic map of the human genes
(Deloukas et al. 1998) contains half the estimated num-
ber of all human genes, which should facilitate the se-
lection and testing of positional candidate genes for the
other periodic fevers. The identity of these genes will
lead to the characterization of molecular pathways for
this group of disorders and to opportunities for study
of how the inflammatory processes are regulated by each
of these genes. They could be homologues of MEFV;
they could be structurally unrelated to, but affect the
same pathway as,MEFV; or their products may interact
with pyrin (or marenostrin), theMEFV protein product.
Alternatively, the different genes involved may affect dif-
ferent and independent pathways. The positional can-
didate approach to gene identification now has the po-
tential to swiftly dissect the remaining genetic loci and
to define the molecular basis for all the periodic fevers.
Mutational and functional analyses of the genes involved
may then lead to identification of the environmental trig-
gers that interact with the different defective gene prod-
ucts and are responsible for the periodicity of the in-
flammatory process. Modification of environmental
components that trigger the onset of periodic fever, to-
gether with the genetic identification of patients by lab-
oratory-based diagnosis, may soon lead to better man-
agement for members of families with hereditary
periodic fevers.
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